DOI QR코드

DOI QR Code

Effect of Lymphangiogenesis and Lymphovascular Invasion on the Survival Pattern of Breast Cancer Patients

  • Sahoo, Pradyumna Kumar (Department of Surgical Oncology, Saroj Gupta Cancer Centre and Research Institute) ;
  • Jana, Debarshi (Institute of Post Graduate Medical Education & Research (IPGME&R) and Seth Sukhlal Karnani Memorial Hospital (SSKM)) ;
  • Mandal, Palash Kumar (Department of Pathology, North Bengal Medical College) ;
  • Basak, Samindranath (Department of Surgical Oncology, Saroj Gupta Cancer Centre and Research Institute)
  • Published : 2014.08.15

Abstract

Background: Invasion of breast cancer cells into blood and lymphatic vessels is one of the most important steps for metastasis. In this study the prognostic relevance of lymphangiogenesis and lymphovascular invasion (LVI) in breast cancer patients was evaluated in terms of survival. Materials and Methods: This retrospective study concerned 518 breast cancer patients who were treated at Department of Surgical Oncology, Saroj Gupta Cancer Centre and Research Institute, Kolkata-700063, West Bengal, India, a reputed cancer centre and research institute of eastern India between January 2006 and December 2007. Results: The median overall survival and disease free survival of the patients were 60 months and 54 months respectively. As per Log-rank test, poor overall as well as disease free survival pattern was observed for LVI positive patients as compared with LVI negative patients (p<0.01). Also poor overall as well as disease free survival pattern was observed for perineural invasion (PNI) positive patients as compared to PNI negative patients (p<0.01). Conclusions: From this study it is evident that LVI and PNI are strongly associated with outcome in terms of disease free as well as overall survival in breast cancer patients. Thus LVI and PNI constitute potential targets for treatment of breast cancer patients. We advocate incorporating their status into breast cancer staging systems.

Keywords

References

  1. Carter CL, Allen C, Henson DE (1989). Relation of tumour size, lymph node status, and survival in 24,740 BC Cases. Cancer, 63, 181-7. https://doi.org/10.1002/1097-0142(19890101)63:1<181::AID-CNCR2820630129>3.0.CO;2-H
  2. Cooke T, Reeves J, Lanigan A, Stanton P (2001). HER2 as a prognostic and predictive marker for breast cancer. Ann Oncol, 1, 23-8.
  3. Das S, Sen S, Mukherjee A, Chakraborty D, Mondal PK (2012). Risk factors of breast cancer among women in eastern India: a tertiary hospital based case control study. Asian Pac J Cancer Prev, 13, 4979-81. https://doi.org/10.7314/APJCP.2012.13.10.4979
  4. Desmedt C, Haibe-Kains B, Wirapati P, et al (2008). Biological process associated with breast cancer clinical outcome depend on the molecular subtypes. Clin Cancer Res, 14, 5158-65. https://doi.org/10.1158/1078-0432.CCR-07-4756
  5. Donegan WL (1997). Tumor-related prognostic factors for breast cancer. CA Cancer J Clin, 47, 28-51. https://doi.org/10.3322/canjclin.47.1.28
  6. Ferlay J, Shin HR, Bray F, et al (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer, 127, 2893-917. https://doi.org/10.1002/ijc.25516
  7. Ferno M (1998). Prognostic factors in breast cancer: a brief review. Anticancer Res, 18, 2167-71.
  8. Henson DE, Ries L, Freedman LS, Carriaga M (1991). Relationship among outcome, stage of disease, and histologic grade for 22,616 cases of breast cancer. The basis for a prognostic index. Cancer, 68, 2142-9. https://doi.org/10.1002/1097-0142(19911115)68:10<2142::AID-CNCR2820681010>3.0.CO;2-D
  9. Jana D, Das S, Sarkar DK, et al (2012). Role of nuclear factor-$\kappa{b}$ in female breast cancer: a study in Indian patients. Asian Pac J Cancer Prev, 13, 5511-5. https://doi.org/10.7314/APJCP.2012.13.11.5511
  10. Jana D, Mandal S, Mukhopadhyay M, et al (2012). Prognostic significance of HER-2/neu and survival of breast cancer patients attending a specialized breast clinic in Kolkata, Eastern India. Asian Pac J Cancer Prev, 13, 3851-5. https://doi.org/10.7314/APJCP.2012.13.8.3851
  11. Karak SG, Quatrano N, Buckley J, Ricci A Jr (2010). Prevalence and significance of perineural invasion in invasive breast carcinoma. Conn Med, 74, 17-21.
  12. Khokhar A (2012). Breast cancer in India: Where do we stand and where do we go? Asian Pac J Cancer Prev, 13, 4861-6. https://doi.org/10.7314/APJCP.2012.13.10.4861
  13. KK Ma, Wai Wang Chau, Connie HN Wong, et al (2012). Triple negative status is a poor prognostic indicator in chinese women with breast cancer: a ten year review. Asian Pac J Cancer Prev, 13, 2109-14. https://doi.org/10.7314/APJCP.2012.13.5.2109
  14. Laguens G, Coronato S, Di Girolamo (2006). Biomarkers in breast cancer. CEJ Med, 1, 330-47.
  15. Lee AH (2005). Why is carcinoma of the breast more frequent in the upper outer quadrant? a case series based on needle core biopsy diagnoses. Breast, 14, 151-2. https://doi.org/10.1016/j.breast.2004.07.002
  16. Michaelson JS, Silverstein PM, Wyatt J, et al (2002). Predicting the survival of patients with breast carcinoma using tumor size. Cancer, 95, 713-23. https://doi.org/10.1002/cncr.10742
  17. Muhammadnejad S, Muhammadnejad A, Haddadi M, et al (2013). Correlation of microvessel density with nuclear pleomorphism, mitotic count and vascular invasion in breast and prostate cancers at preclinical and clinical levels. Asian Pac J Cancer Prev, 14, 63-8. https://doi.org/10.7314/APJCP.2013.14.1.63
  18. Nathanson SD, Zarbo RJ, Wachna DL, et al (2000). Microvessels that predict axillary lymph node metastases in patients with breast cancer. Arch Surg, 135, 586-93. https://doi.org/10.1001/archsurg.135.5.586
  19. Noel W, Joseph PS, Willian RW, Judah F (1991). Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med, 324, 1-8. https://doi.org/10.1056/NEJM199101033240101
  20. Sarkar DK, Jana D, P. S. Patil, et al (2013). Role of NF-$\kappa{B}$ as a prognostic marker in breast cancer: a pilot study in Indian patients. Indian J Surg Oncol, 13, 0234-8.
  21. Schnitt SJ (2001). Traditional and newer pathologic factors. J Natl Cancer Inst, 30, 22-6.
  22. Sebastian FS, Guenther B, Aumayr K , et al (2004). Prognostic value of lymphangiogenesis and lymphovascular invasion in invasive breast cancer. Ann Surg, 240, 306-12. https://doi.org/10.1097/01.sla.0000133355.48672.22
  23. Sen U, Sankaranarayanan R, Mandal S, et al (2002). Cancer patterns in eastern India: The first report of the Kolkata cancer registry. Int J Cancer, 100, 86-91. https://doi.org/10.1002/ijc.10446
  24. Tan LGL, Tan YY, Heng D, Chan MY (2005). Predictors of axillary lymph node metastases in women with early breast cancer in Singapore. Singapore Med J, 46, 693-7.
  25. Thames HD, Buchholz TA, Smith CD (1999). Frequency of first metastatic events in breast cancer: implications for sequencing of systemic and local-regional treatment. J Clin Oncol, 17, 2649-58.
  26. Widodo I, Ferronika P, Harijadi A, et al (2013). Clinicopathological signifcance of lymphangiogenesis and tumor lymphovascular invasion in Indonesian breast cancers. Asian Pac J Cancer Prev, 14, 997-1001. https://doi.org/10.7314/APJCP.2013.14.2.997

Cited by

  1. Angiolymphatic invasion as a prognostic fator in resected N0 pancreatic adenocarcinoma vol.30, pp.1, 2017, https://doi.org/10.1590/0102-6720201700010012
  2. Computer-aided prognosis on breast cancer with hematoxylin and eosin histopathology images: A review vol.39, pp.3, 2017, https://doi.org/10.1177/1010428317694550
  3. Metastatic and triple-negative breast cancer: challenges and treatment options vol.8, pp.5, 2018, https://doi.org/10.1007/s13346-018-0551-3